ESPI Current Report, No. 9/2023, Conclusion of a framework agreement for the supply of products

10-03-2023 17:03:17 | Current | ESPI | 9/2023

Legal basis
Article 17 (1) MAR – confidential information.
Contents of the report:
The Management Board of Mycodern S.A., headquartered in Gdańsk _previously Median Polska S.A., headquartered in Mysłowice; hereinafter: the Company_ informs that today it has entered into a contract with Swisspharm sp. z o.o. sp.k. headquartered in Olsztyn _hereinafter: the Counterparty_, a framework supply agreement, based on which the Company undertook to manufacture according to the Counterparty’s design documentation and for its benefit, and to supply jellybeans based on orders placed by the Counterparty. The Contracting Party has the right, at its own expense, to inspect and/or audit the production process and storage of the ordered products in order to control the production conditions. The Agreement does not contain any quantity or value commitments as to the execution of orders by the Contracting Party. This agreement is of a framework nature and is concluded for an indefinite period of time. Either party may terminate this agreement at one month’s notice. The agreement may be
terminated also with immediate effect in the event of non-fulfillment of its provisions by the other party.At the same time, the Management Board informs that the Counterparty, together with the signing of this agreement, has placed the
first order, the value of which is estimated at approximately PLN 111 thousand net.

  • Piotr Zawadzki- President of the Management Board

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top